Robert Michael Floyd Processa Pharmaceuticals, Inc. (PCSA) insider trading activity

Robert Michael Floyd is Chief Operating Officer of Processa Pharmaceuticals, Inc.. Currently has a direct ownership of 82,267 shares of PCSA, which is worth approximately $80,621. The most recent transaction as insider was on Feb 09, 2023, when has been sold 10,000 shares (Common Stock) at a price of $0.8 per share, resulting in proceeds of $8,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.3K

0% 3M change

0% 12M change

Total Value Held $80,621

Robert Michael Floyd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 09 2023	BUY Grant, award, or other acquisition	$8,000 $0.8 p/Share	10,000 Added 10.84%	82,267 Common Stock
Oct 06 2022	SELL Payment of exercise price or tax liability	-	4,163 Reduced 5.45%	72,267 Common Stock
Oct 06 2022	BUY Exercise of conversion of derivative security	-	12,500 Added 14.06%	76,430 Common Stock
Aug 16 2022	SELL Bona fide gift	-	7,000 Reduced 9.87%	63,930 Common Stock
Mar 31 2022	SELL Bona fide gift	-	7,000 Reduced 8.98%	70,930 Common Stock
Oct 06 2021	SELL Payment of exercise price or tax liability	-	4,663 Reduced 33.19%	9,387 Common Stock
Oct 06 2021	BUY Exercise of conversion of derivative security	-	12,500 Added 46.3%	14,500 Common Stock
Jun 22 2021	BUY Open market or private purchase	$14,060 $7.03 p/Share	2,000 Added 6.67%	28,000 Common Stock

RMF

Robert Michael Floyd

Chief Operating Officer

Hanover, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCSA shares.

Notify only if

Value

Insider Trading

Get notified when an Processa Pharmaceuticals, Inc. insider buys or sells PCSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Processa Pharmaceuticals, Inc.

Track Activities on PCSA

Account